Next Generation Sequencing (NGS) Market Poised to Hit $42.25 Billion by 2033: Key Drivers Behind the Surge - Latest Study by Grand View Research, Inc.

As millions of Canadians continue to struggle with barriers to healthcare, a growing number of patients want to see more health services provided by their local pharmacies, according to new research ...

The global biotechnology market is expected to grow at a rate of 13-15% over the next five years. Key drivers of this growth include advancements in genetic engineering and genomics, an increasing ...

New England Biolabs (NEB®) today announces the release of the NEBNext Flu A Integrated Indexing Primer Module (NEB #E3436), designed to streamline and scale the sequencing of Influenza A virus from a ...

The review also calls for embedding diagnostics within the One Health framework, which integrates human, animal, and ...

Nucleic acid testing (NAT) identifies specific pathogen genetic material (DNA or RNA), enabling early and precise diagnosis ...

Q3 U.S. Galleri Revenue Grew 28% Year-Over-Year to $32.6 Million Q3 Galleri Tests Sold Grew 39% Year-Over-Year to More Than 45,000 Galleri PMA Submission ...

QUT researchers have recovered the genomes of more than 24,000 previously unknown microbial species—some from entirely new ...

The Global Usher Syndrome Market is estimated to be valued at USD 2.29 Bn in 2025 and is expected to reach USD 3.20 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 4.9% from 2025 to ...

Absci accelerates ABS-201 in alopecia & endometriosis, targets data by 2027, and refocuses pipeline for value.